Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
600MPE
HR+
Luminal
PD173074
FGFR1/3
RTK
5898.093
uM
7.82560
10.48720
-0.9800 -1.0000 3.7527 0.3030
0.9267
0.6963
600MPE
HR+
Luminal
PD 98059
MEK
MAPK
12224.152
uM
124.1750
739.75820
0.6747 -1.0000 0.6156 0.0605
0.8626
1.0761
600MPE
HR+
Luminal
Oxamflatin
HDAC
HDAC
12224.147
uM
2.79220
7.38130
-0.9880 -1.0000 1.1301 0.3828
0.9872
0.8621
600MPE
HR+
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
9120.021
uM
16.89330
40.58020
-0.9570 -1.0000 1.2536 0.4435
0.9886
0.6486
184A1
NM
Basal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5894.095
uM
53.72510
62.72890
-0.1792 -0.0920 1.0901 0.3508
0.940
1.7133
600MPE
HR+
Luminal
Omipalisib
PI3K
PI3K
5898.086
uM
0.00518
0.03234
-0.9192 -0.9919 0.5968 1.0821
0.9909
0.5904
600MPE
HR+
Luminal
Olomoucine II
CDK1
CDK
12224.147
uM
5.58170
10.43060
-0.8385 -0.8767 1.6199 0.4077
0.9941
0.8621
600MPE
HR+
Luminal
Nutlin 3a
MDM2
MDM2
5898.066
uM
21.57430
55.22930
-0.1137 -1.0000 1.1687 0.2041
0.8254
0.6097
184A1
NM
Basal
Gemcitabine
DNA replication
DNA replication
9047.011
uM
0.39288
3.58790
-0.7197 -1.0000 0.4967 0.6665
0.9520
0.6293
600MPE
HR+
Luminal
NU6102
CDK1/2
CDK
12224.147
uM
13.35890
16.51910
-0.9366 -0.9385 4.9766 0.1740
0.9959
0.8621
600MPE
HR+
Luminal
NSC 663284
CDC25
CDC
12224.152
uM
3.0690
3.80580
-0.9666 -0.9662 5.0000 0.6239
0.9973
1.0761
600MPE
HR+
Luminal
Nilotinib
ABL
nRTK
12224.145
uM
inf
inf
0.9894 0.9894 0.0000 -0.0249
-0.6099
0.9737
600MPE
HR+
Luminal
Nelfinavir
13091.174
uM
7.89670
11.89710
-0.8885 -1.0000 2.6806 0.2337
0.9761
0.7967
184B5
NM
Basal
Imatinib
ABL/KIT/PDGFR
nRTK
5897.091
uM
24.73780
35.23660
-0.9547 -0.9568 3.0230 0.4186
0.9990
1.2296
600MPE
HR+
Luminal
MG-132
Proteasome
Proteasome
12224.145
uM
0.48313
0.59815
-0.9678 -0.9541 4.9993 0.6869
0.9988
0.9737
600MPE
HR+
Luminal
MG-132
Proteasome
Proteasome
12224.145
uM
0.48313
0.59815
-0.9678 -0.9541 4.9993 0.6869
0.9988
0.9737
600MPE
HR+
Luminal
MG-132
Proteasome
Proteasome
14197.189
uM
0.51937
0.56031
-0.0819 -0.2307 5.0000 0.4836
0.9433
1.3593
600MPE
HR+
Luminal
MG-132
Proteasome
Proteasome
14197.189
uM
0.51937
0.56031
-0.0819 -0.2307 5.0000 0.4836
0.9433
1.3593
600MPE
HR+
Luminal
Methylglyoxal
13091.184
uM
541.6520
823.99310
-0.9999 -0.9709 2.5719 0.6677
0.9952
0.8014
600MPE
HR+
Luminal
Methotrexate
DHFR
Metabolism
5898.085
uM
0.04275
0.02134
0.1899 0.2364 0.9210 0.5707
0.9492
0.7048
600MPE
HR+
Luminal
Methotrexate
DHFR
Metabolism
5899.084
uM
inf
124.59710
0.7402 0.5425 0.2308 0.1158
0.6762
1.1144
600MPE
HR+
Luminal
Mebendazole
13091.174
uM
14.64610
480.70650
0.3243 -1.0000 0.3147 0.2245
0.8786
0.7967
600MPE
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12224.154
uM
1.54780
2.65610
-0.9808 -0.9927 2.0253 0.4248
0.9948
0.9590
184B5
NM
Basal
GW-5074
CRAF
MAPK
5897.088
uM
2.70550
3.11820
-0.1725 -0.1816 2.1826 0.2410
0.9894
1.2950
600MPE
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
5899.098
uM
inf
43.7290
0.7237 0.4664 0.1327 0.1531
0.7519
1.1012